Since LHX6 was found to promote normal palate development through mediating cell cycle33, it is hypothesized that LHX6 may overcome the resistance to EGFR-TKIs in NSCLC through mediating the expression of cell cycle-, apoptosis- and proliferation-associated genes. The gene discussed is LHX6; the disease is non-small cell lung carcinoma.